Valuation: Johnson & Johnson

Capitalization 487B 418B 392B 365B 674B 43,785B 734B 4,582B 1,769B 20,679B 1,826B 1,787B 75,612B P/E ratio 2025 *
19.3x
P/E ratio 2026 * 21.3x
Enterprise value 507B 436B 408B 381B 703B 45,631B 765B 4,776B 1,844B 21,551B 1,903B 1,862B 78,800B EV / Sales 2025 *
5.41x
EV / Sales 2026 * 5.08x
Free-Float
77.08%
Yield 2025 *
2.56%
Yield 2026 * 2.64%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.27%
1 week-2.41%
Current month-2.41%
1 month+8.00%
3 months+13.17%
6 months+30.25%
Current year+39.63%
More quotes
1 week 200.81
Extreme 200.81
207.7
1 month 185.12
Extreme 185.12
207.81
Current year 140.68
Extreme 140.68
207.81
1 year 140.68
Extreme 140.68
207.81
3 years 140.68
Extreme 140.68
207.81
5 years 140.68
Extreme 140.68
207.81
10 years 94.28
Extreme 94.28
207.81
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 03/01/2022
Director of Finance/CFO 58 01/07/2018
Chief Tech/Sci/R&D Officer 60 01/08/2024
Director TitleAgeSince
Director/Board Member 72 23/10/2009
Director/Board Member 61 15/10/2013
Director/Board Member 70 09/06/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.27%-2.41%+35.24%+14.67% 487B
-0.41%-6.06%+22.21%+174.14% 905B
-1.15%-0.71%+28.32%+38.09% 400B
+0.26%+1.14%+20.97%+1.87% 330B
+0.58%-2.73%+27.58%+21.90% 281B
+0.19%+2.49%+19.23%+25.56% 255B
-1.16%-4.87%-3.27%-8.45% 248B
+1.24%-2.33%-60.59%-30.82% 214B
-3.02%-4.51%+21.03%+16.45% 178B
-1.14%-3.67%+31.57%+37.81% 150B
Average -0.49%-2.37%+14.23%+29.12% 344.69B
Weighted average by Cap. -0.40%-2.83%+18.23%+56.02%
See all sector performances

Financials

2025 *2026 *
Net sales 93.75B 80.59B 75.49B 70.37B 130B 8,437B 141B 883B 341B 3,985B 352B 344B 14,570B 98.44B 84.62B 79.27B 73.88B 136B 8,859B 148B 927B 358B 4,184B 369B 362B 15,299B
Net income 24.78B 21.3B 19.95B 18.6B 34.35B 2,230B 37.36B 233B 90.11B 1,053B 92.99B 91.01B 3,851B 22.4B 19.26B 18.04B 16.81B 31.05B 2,016B 33.78B 211B 81.46B 952B 84.07B 82.28B 3,481B
Net Debt 20.52B 17.64B 16.52B 15.4B 28.44B 1,846B 30.94B 193B 74.61B 872B 77B 75.36B 3,188B 13.42B 11.53B 10.8B 10.07B 18.6B 1,208B 20.23B 126B 48.8B 570B 50.36B 49.28B 2,085B
More financial data * Estimated data
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2024, Johnson & Johnson has 64 manufacturing facilities located in the United States (23), North America (7), Europe (21), Africa and Asia/Pacific (13). The United States accounts for 56.6% of net sales.
Employees
138,100
More about the company
Date Price Change Volume
05/12/25 201.93 $ -0.27% 7,785,552
04/12/25 202.48 $ -1.39% 9,049,943
03/12/25 205.33 $ -0.04% 8,363,292
02/12/25 205.42 $ +0.04% 8,393,565
01/12/25 205.34 $ -0.76% 8,473,726

Delayed Quote Nyse, December 06, 2025 at 05:00 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
201.93USD
Average target price
203.42USD
Spread / Average Target
+0.74%
Consensus

Quarterly revenue - Rate of surprise